Company profile
Nuritas
AI-discovered peptides for health and wellness product formulations.
- Category
- Healthcare AI
- Headquarters
- Dublin, Ireland
- Sells to
- Mixed
- Business model
- Other
- Deployment
- Not stated
- Pricing
- Not published
- Builds own models
- Yes
- Modalities
- Other
What Nuritas does
Nuritas uses artificial intelligence to discover and clinically validate cell-signaling peptide ingredients from nature for product formulations. Their proprietary AI platform, The Nuritas Magnifier, identifies, unlocks, and validates smart peptides from natural sources, significantly accelerating the discovery process compared to traditional methods. These peptides are designed to empower healthier lives by making everyday products more efficacious, safer, and greener. Nuritas focuses on translating nature's wisdom into innovative ingredients for various health outcomes, including muscle health, sleep support, and skin rejuvenation. The company aims to revolutionize human health at scale by making healthier ingredients accessible in every product.
Products
- The Nuritas Magnifier NπΦ™A proprietary AI platform purpose-built for peptide biology, trained on biological outcomes to scan billions of peptide sequences in plants, identify signals, and predict their behavior in the human body. It accelerates peptide discovery and validation, modeling bioavailability and safety before lab work.
- SmartPeptides™A category of AI-discovered, clinically validated, food-derived peptides that work as active biological signals to influence multiple bodily systems. They are precision-targeted and proven to work in humans.
- PeptiStrong®Clinically studied plant peptides from fava beans that signal cells to support muscle strength, recovery, and energy. It works via MTOR and Phospho-S6 pathways to increase muscle synthesis, reduce muscle breakdown, increase mitochondrial mass, and improve strength recovery.
- PeptiSleep™Natural plant peptides from brown rice designed to support complete sleep, including deep and REM sleep, without grogginess. It works by reducing cortisol levels, a hormone that keeps you alert.
- PeptiYouth™The world's first AI-discovered anti-aging peptide, clinically tested to reduce the appearance of wrinkle depth, smoothen skin, reduce skin roughness, and support collagen production.
Key capabilities
- AI-powered peptide discovery and validation (The Nuritas Magnifier)
- Largest library of natural peptides with known functionalities (over 8M identified)
- Precision in predicting peptide in vitro clinical efficacy (80% success rate)
- Clinically proven ingredients with human clinical trials
- Food-derived, plant-based peptides
- Targeted cell-signaling mechanisms
- Accelerated discovery process (10x faster than traditional methods)
- High accuracy in discovery (600x more accurate than traditional methods)
- Bioavailability and safety modeling before lab work
- Proprietary proteomics analysis for mechanism of action mapping
- 56 patents issued
Use cases
- Developing health solutions
- Formulating new products with peptide ingredients
- Improving muscle health (strength, recovery, energy)
- Enhancing sleep quality (falling asleep, staying asleep, deep/REM sleep)
- Reducing deep wrinkles and improving skin vitality
- Creating healthier, safer, greener, and more efficacious everyday products
AI approach
Nuritas uses its proprietary AI platform, The Nuritas Magnifier NπΦ™, to discover and clinically validate bioactive peptides from natural sources. This platform is purpose-built for peptide biology, trained on biological outcomes to scan billions of peptide sequences, identify relevant signals, and predict their behavior in the human body. The process involves AI-powered candidate screening, bioavailability & safety modeling, and proprietary proteomics analysis.
Tech named: The Nuritas Magnifier NπΦ™, proprietary AI platform, AI-powered candidate screening, Bioavailability & Safety Modelling, Proprietary Proteomics Analysis
Industries served
- Biotechnology
- Food and Beverage
- Nutraceuticals
- Cosmetics
- Health and Wellness
What it says sets it apart
- Proprietary AI platform (The Nuritas Magnifier) for peptide discovery
- Ability to discover and validate peptides in months, not decades
- Focus on food-derived, natural peptides
- Extensive clinical validation for all ingredients
- Precision-targeted, cell-signaling peptides
- Vast library of natural peptides with known functionalities
- High success rate in predicting clinical efficacy
- Backed by peer-reviewed science and academic achievements
Funding rounds we track
M&G Investment, McWin Capital Partners, Grosvenor, ECBF
From the AI funding tracker — rounds as reported by the linked publications.
This profile was compiled from Nuritas's own public pages in July 2026 and reflects what the company states about itself — not an endorsement or an independent audit of those claims. Facts are extracted with AI and filtered by an automated check that drops any named product, customer or certification missing from the source pages. Full method. Something out of date? Tell us.